The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15–16 years in Italy

Author:

Visioli Carmen B1ORCID,Giorgi Rossi Paolo2ORCID,Armaroli Paola3,Iossa Anna4,Rizzolo Raffaella3,Bonelli Luigina A5,Venturino Ezio6ORCID,Carozzi Francesca M7,Bisanzi Simonetta7ORCID,De Marco Laura3,Giordano Livia3,Camussi Elisa3,Del Mistro Annarosa8,Zappa Marco1

Affiliation:

1. Clinical Epidemiology and Clinical Governance Support Unit, Oncological Network, Prevention and Research Institute (ISPRO), Florence, Italy

2. Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy

3. Cancer Epidemiology Unit and Centre for Cancer Prevention (CPO), City of Health and Science Hospital, Turin, Italy

4. Screening and Secondary Prevention Unit, Oncological Network, Prevention and Research Institute (ISPRO), Florence, Italy

5. Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

6. Pathological Anatomy Unit, ASL2 Liguria, San Paolo Hospital, Savona, Italy

7. Regional Laboratory for Cancer Prevention, Oncological Network, Prevention and Research Institute (ISPRO), Florence, Italy

8. Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy

Abstract

Objective To evaluate the association between human papillomavirus vaccination status and participation in cervical cancer screening (at age 25) by the first cohorts of girls who were offered vaccination at the age of 15 to 16 years in Italy. Methods Women born in 1993, 1994 and 1995 were invited to participate in cervical cancer screening between 2018 and 2020. We report participation in screening by vaccination status in three large areas, Florence province, Piedmont region and Savona province, where the Consensus Project was carried out. The relative risk of participation among vaccinated (≥2 doses) and unvaccinated women was estimated. Odds ratios (OR) of participation by vaccination status were estimated by logistic regression, adjusted by birthplace and birth cohort. Results Overall, 34,993 women were invited for screening: 13,006 (37.2%) participated and 10,062 of these agreed to participate in the Consensus intervention study. Among the invited women and screening participants, vaccinated women were 51.0% and 60.6%, respectively. Comparing vaccinated and unvaccinated women, the adjusted OR of screening participation was 1.80 (95% confidence interval (CI): 1.72–1.89), 2.17 (95% CI: 1.94–2.42), 1.59 (95% CI: 1.50–1.68) and 1.15 (95% CI: 0.86–1.54) for overall, Florence, Piedmont and Savona, respectively. About 33% of the invited women were unvaccinated and did not participate in screening: 25.8%, 59.5% and 64.2% of women born in Italy, in high migration pressure countries and in advanced development countries, respectively. Conclusions Screening participation was higher among vaccinated than unvaccinated women. Active policies are needed to reduce inequalities, targeting the unscreened and unvaccinated population, particularly non-native women, to accelerate cervical cancer elimination in Italy.

Funder

Italian Ministry of Health

Publisher

SAGE Publications

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference39 articles.

1. Conference of the State and Regions. Agreement between the Central Government, Regions and Autonomous Provinces of Trento and Bolzano regarding the strategy for the active offer of the vaccine against HPV infection in Italy (2007) [in Italian]. Available from: http://archivio.statoregioni.it/DettaglioDoc6941.html?IDDoc=16696&IdProv=5285&tipodoc=2&CONF=CSR (accessed 2 February 2023).

2. Giambi C. Department of Epidemiology of Infectious Diseases of CNESPS, ISS. Recognition of regional decisions regarding HPV vaccination and first data on vaccination coverage at the end of 2009 (2010) [in Italian]. Available from: https://www.epicentro.iss.it/hpv/pdf/HPV-2009.pdf (accessed 2 February 2023).

3. Human papilloma virus vaccination: impact and recommendations across the world

4. Italian Republic, Official Gazette, General Series No 43 of February 21, 2017. DETERMINATION February 16, 2017. Classification of the medicinal product for human use “Gardasil 9” (2017). [in Italian]. Available from: https://www.gazzettaufficiale.it/eli/gu/2017/02/21/43/sg/pdf (accessed 2 February 2023).

5. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3